Tech Center 1600 • Art Units: 1645 1657
This examiner grants 42% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19305204 | IMMUNOMODULATORY COMPOSITIONS AND METHODS | Non-Final OA | Innate Biologics LLC |
| 17921788 | COMPOSITION FOR IMPROVING IMMUNITY | Final Rejection | The Chinese University of Hong Kong |
| 17410360 | PROBIOTICS AND PROBIOTIC COMPOSITIONS HAVING MODIFIED CARBOHYDRATE METABOLISM | Final Rejection | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
| 17971072 | MICROBIOME TRANSPLANTATION FOR OSTEOARTHRITIS THERAPY | Final Rejection | The Board of Regents of the University of Oklahoma |
| 17266717 | MICROORGANISM MIXTURES, MOLECULES DERIVED THEREFROM, AND METHODS OF USE THEREOF | Non-Final OA | B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY |
| 17258863 | SUPPORTED PLANT PLASMA MEMBRANE LIPID BILAYER ON-A-CHIP | Non-Final OA | Cornell University |
| 17283265 | Fermented formula with non-digestible oligosaccharides for use in rotavirus induced infection | Non-Final OA | N.V. Nutricia |
| 17283287 | NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND DIETARY BUTYRATE | Non-Final OA | N.V. Nutricia |
| 17618927 | Alpha-Amylase Variants | Final Rejection | Novozymes A/S |
| 17601019 | Liquid Dishwashing Detergent Compositions | Non-Final OA | Novozymes A/S |
| 18051017 | COMPOSITION FOR IMPROVING GUT MICROBIOTA AND METHOD FOR IMPROVING GUT MICROBIOTA WITH THE COMPOSITION THEREOF | Non-Final OA | TCI CO., LTD. |
| 18569805 | Compositions Comprising Microbes and Methods of Use and Making Thereof | Non-Final OA | Pendulum Therapeutics, Inc. |
| 17587166 | PSEUDOMONAS CHLORORAPHIS SPECIES AND ITS USE IN THE CONTROL OF DISEASES CAUSED BY BACTERIA AND FUNGI | Non-Final OA | UWM RESEARCH FOUNDATION, INC. |
| 18484738 | IMMUNE CHECKPOINT SUPPRESSANT | Final Rejection | NIHON SIZEN HAKKOH CO., LTD. |
| 17917458 | USE OF BACTERIAL STRAINS LACTOBACILLUS BREVIS, LACTOBACILLUS PLANTARUM AND/OR LACTOBACILLUS PENTOSUS IN THE REDUCTION OF AN INGESTED OR ACCUMULATED AMOUNT OF PHOSPHONATES IN THE HUMAN MICROBIOTA | Non-Final OA | PROBIOTICAL S.P.A. |
| 17797891 | COMPOSITION USING NOVEL LACTOBACILLUS PLANTARUM KC3 STRAIN FOR PREVENTION OR TREATMENT OF IMMUNE IMPAIRMENT, RESPIRATORY INFLAMMATORY DISEASE, ALLERGY, AND ASTHMA AND USE THEREOF | Non-Final OA | CKD BIO CORPORATION |
| 17751943 | METHODS TO PRODUCE DEFINED, SPHERICAL, BIO-DEGRADABLE MACROPOROUS MICROCARRIER/HYDROGELS FOR CELLULAR AGRICULTURE | Final Rejection | Innocent Meat GmbH |
| 17746731 | Bacillus strains improving health and performance of production animals | Non-Final OA | Adisseo France SAS |
| 17646581 | PROTEIN STABILIZED LIPOSOMES (PSL) AND METHODS OF MAKING THEREOF | Non-Final OA | Lipotope, LLC |
| 17606145 | COMPOSITION CONTAINING GLUCORAPHANIN AND USE THEREOF | Final Rejection | SHENZHEN FUSHAN BIOTECH CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy